HUMAN PARVOVIRUS В19: VIRUS CHARACTERISTICS, DISTRIBUTION AND DIAGNOSTICS OF PARVOVIRUS INFECTION

Cover Page


Cite item

Full Text

Abstract

Abstract. The modern data about morphology as well as structural and functional organization of the parvovirus B19 genome, circulating virus genotypes are presented in the review. Special attention was paid to the clinical and epidemiological features of parvovirus infection (PVI). Authors focused on the distribution of PVI in different regions of Russia and on the own data concerning prevalence of this infection in the North-Western region of the country including data on pregnant women – main risk group for PVI. Methods of laboratory diagnostics of postnatal and congenital PVI have been described.

About the authors

I. N. Lavrentyeva

St. Petersburg Pasteur Institute, St. Petersburg

Author for correspondence.
Email: pasteur.lawr@mail.ru

PhD, MD (Medicine), Head of the Laboratory of Childhood Viral Infections

197101, Russian Federation, St. Petersburg, Mira str., 14

Russian Federation

A. Y. Antipova

St. Petersburg Pasteur Institute, St. Petersburg

Email: pasteur.lawr@mail.ru
Researcher, Laboratory of Childhood Viral Infections Russian Federation

References

  1. Алимбарова, Л.М. Парвовирусы (Parvoviridaе) // Медицинская вирусология: руководство; под ред. Д.К. Львова. — М.: ООО «Медицинское информационное агентство», 2008. — С. 276–284. Alimbarova, L.M. Parvovirusy (Parvoviridae). Meditsinskaya virusologiya: rukovodstvo (pod red. D.K. L`vova) [Parvoviruses (Parvoviridaе). Medical Virology: manual (Ed. by L’vov D.K.)]. Moscow: Medical information agency, 2008, pp. 276–284.
  2. Антипова А.Ю. Значение лабораторной диагностики краснушной и парвовирусной инфекций в период элиминации краснухи: автореф. дис. … канд. биол. наук. — СПб., 2013. — 22 с. Antipova A.Yu. Znachenie laboratornoy diagnostiki krasnushnoy i parvovirusnoy infektsiy v period eliminatsii krasnukhi: avtoref. dis. kand. biol. nauk [Significance of laboratory diagnostics of rubella and parvoviral infections in the period of rubella elimination. Cand. biol. sci. diss]. St. Petersburg, 2013, 22 p.
  3. Антипова А.Ю., Лаврентьева И.Н., Бичурина М.А., Лялина Л.В., Кутуева Ф.Р. Распространение парвовирусной инфекции в Северо-Западном федеральном округе России // Журнал инфектологии. — 2011. — Т. 3, № 4. — С. 44–48. Antipova A.Yu., Lavrent`eva I.N., Bichurina M.A., Lyalina L.V., Kutueva F.R. Rasprostranenie parvovirusnoy infektsii v Severo-Zapadnom federal`nom okruge Rossii [Prevalence of parvoviral infection in the North Western federal district of Russia]. Zhurnal infektologii — Journal of Infectology, 2011, vol. 3, no. 4, рр. 44–48.
  4. Бичурина М.А., Каплун И.Я., Москалева Т.Н., Крылова И.В, Антипова А.Ю., Качнов В.А. Проблемы диагностики краснухи на современном этапе // Проблемы современной эпидемиологии. Перспективные средства и методы лабораторной диагностики и профилактики актуальных инфекций: труды Всероссийской научной конференции 19–20 ноября 2009 года. — СПб.: Литография, 2009. — С. 99–100. Bichurina M.A., Kaplun I.Ya., Moskaliova T.N., Krylova I.V, Antipova A.Yu., Kachnov V.A. Problemy diagnostiki krasnukhi na sovremennom etape [Morden problems of Rubella diagnostics]. Problemy sovremennoy epidemiologii. Perspektivnye sredstva i metody laboratornoy diagnostiki i profilaktiki aktual`nykh infektsiy: trudy Vserossiyskoy nauchnoy konferentsii 19-20 noyabrya 2009 goda [Modern epidemiology problems. Perspective methods actual infections laboratory diagnostics: material of Russian sci. confer. 19–20 November 2009]. St. Petersburg: Lithography, 2009, рр. 99–100.
  5. Васильев В.В., Мурина Е.А., Сидоренко С.В., Мукомолова А.Л., Куюмчъян С.Х., Воронина О.Л., Мирошниченко И.Г., Мацко В.А. Парвовирусная (В19V) инфекция у беременных и детей раннего возраста // Журнал инфектологии. — 2011. — Т. 3, № 4. — С.26–33. Vasil`ev V.V., Murina E.A., Sidorenko S.V., Mukomolova A.L., Kuyumch”yan S.H., Voronina O.L., Miroshnichenko I.G., Matsko V.A. Parvovirusnaya (V19V) infektsiya u beremennykh i detey rannego vozrasta [Parvoviral (B19) infection in pregnant and neonatal child]. Zhurnal infektologii — Journal of Infectology, 2011, vol. 3, рр. 26–33.
  6. Жибурт Е.Б., Баранова О.В., Рейзман П.В., Кузьмин Н.С. Новое в трансфузиологии (на XXVIII Конгрессе Международного общества переливания крови) — Режим доступа: http://www.transfusion.ru/doc/2004-09-03-1.html. — Дата обращения: 26.02.13. — Загл. с экрана. Zhiburt E.B., Baranova O.V., Reyzman P.V., Kuz`min N.S. Novoe v transfuziologii (na XXVIII Kongresse Mezhdunarodnogo obshchestva perelivaniya krovi) [Transfusion news (on XXVIII congress of blood transfusion)]. Available at: http://www.transfusion.ru/doc/2004-09-03-1.html (accessed: 26.02.2013).
  7. Краснуха: эпидемиология, лабораторная диагностика и профилактика в условиях спорадической заболеваемости: аналитический обзор. — СПб.: НИИЭМ им. Пастера, 2010. — 68 с. Krasnukha: epidemiologiya, laboratornaya diagnostika i profilaktika v usloviyakh sporadicheskoy zabolevaemosti: analiticheskiy obzor [Rubella: epidemiology, laboratory diagnostic, prophylactic in sporadic period: analytic revue]. St. Petersburg, Pasteur Institute, 2010. 68 p.
  8. Матвеев В.А., Прощаева Н.В., Самойлович Е.О., Ермолович М.А. Клинико-лабораторная характеристика В19 парвовирусной инфекции // Инфекционные болезни. — 2008. — Т. 6, № 3. — C. 33–37. Matveev V.A., Proshchaeva N.V., Samoylovich E.O., Ermolovich M.A. Kliniko-laboratornaya kharakteristika V19 parvovirusnoy infektsii [B19 parvovirus infection clinical & laboratory characteristics]. Infektsionnye bolezni — Infectious Diseases, 2008, vol. 6, no. 3, pp. 33–37.
  9. O sovershenstvovanii akushersko-ginekologicheskoy pomoshchi v ambulatorno-poliklinicheskikh uchrezhdeniyakh: Prikaz MZ RF № 50 ot 10.02.2003. — 55 s. [About improvement of the obstetric and gynecologic aid in establishments of outpatient clinics and polyclinics. No. 50 order MZ Russian Federation of 10.02.2003., 55 p. Available at: http://www.webapteka.ru/phdocs/doc4528.html].
  10. Об обследовании больных с экзантемой и лихорадкой в рамках реализации Программы ликвидации кори: Приказ МЗ РФ № 33 от 05.02.2010. — 19 с. — Режим доступа: http://34.rospotrebnadzor.ru/documents/ros/18860/print/. — Дата обращения: 27.11.2013. — Загл. с экрана.
  11. Об утверждении технического регламента о требованиях безопасности крови, ее продуктов, кровезамещающих растворов и технических средств, используемых в трансфузионно-инфузионной терапии (с изменениями от 12 октября 2010 г.): Постановление Правительства РФ от 26 января 2010 г. № 29 (ред. от 04.09.2010) (Собрание законодательства Российской Федерации, 2010, № 5, ст. 536). — 31 с. Ob utverzhdenii tekhnicheskogo reglamenta o trebovaniyakh bezopasnosti krovi, ee produktov, krovezameshchayushchikh rastvorov i tekhnicheskikh sredstv, ispol`zuemykh v transfuzionno-infuzionnoy terapii (s izmeneniyami ot 12 oktyabrya 2010 g.): Postanovlenie Pravitel`stva RF ot 26 yanvarya 2010 g. № 29 (red. ot 04.09.2010) [Approval of technical regulations on safety of blood, its products, blood substitutes and the technical facilities used in transfusion and infusion therapy (with changes of October 12, 2010): The resolution of the Government of the Russian Federation of January 26, 2010, No. 29 (an edition of 04.09.2010)]. Sobranie zakonodatel`stva Rossiyskoy Federatsii — The Russian Federation Code, 2010, no. 5, Art. 536]. 31 p.
  12. Общая и частная вирусология / под ред. В.М. Жданова, С.А. Гайдамович. — М.: Медицина, 1986. — Т. 2. — С. 49–95. Obshchaya i chastnaya virusologiya (pod red. V.M. Zhdanova, S.A. Gaydamovich) [General and special virology (Ed. by Zhdanov V.M., Gaidamovich S.A.)]. Moscow: Medicina, 1986, vol. 2, pp. 49–95.
  13. Спиридонова Л.А., Антипова А.Ю., Лаврентьева И.Н., Бичурина М.А., Суркова В.В. Вспышка парвовирусной инфекции в Северо-Западном федеральном округе России // Инфекция и иммунитет. — 2012. — Т. 2, № 3. — С. 665–668. Spiridonova L.A., Antipova A.Yu., Lavrent`eva I.N., Bichurina M.A., Surkova V.V. Vspyshka parvovirusnoy infektsii v Severo-Zapadnom federal`nom okruge Rossii [Parvovirus Infection outbreak in North-West Region Russian Federation]. Infektsiya i immunitet — Infection and Immunity, 2012, vol. 2, no. 3, pp. 665–668.
  14. Тихонова Н.Т., Герасимова А.Г., Москалева Т.Н. Оценка распространения парвовирусной инфекции в Москве // Информационное письмо Комитета здравоохранения г. Москвы. — М., 2004. — № 11. — 12 с. Tikhonova N.T., Gerasimova A.G., Moskaleva T.N. Otsenka rasprostraneniya parvovirusnoy infektsii v Moskve / Informatsionnoe pis`mo Komiteta zdravookhraneniya g. Moskvy [Evaluation of parvoviral infection prevalence in Moscow. Information letter Moscow department of public health]. Moscow, 2004, no. 11, 12 p.
  15. Филатова Е.В., Новикова Н.А, Зубкова Н.В., Голицына Л.Н., Кузнецов К.В. Определение маркеров парвовируса В19 в образцах крови доноров // Журнал микробиологии, эпидемиологии и иммунобиологии. — 2010. — № 5. — С. 67–70. Filatova E.V., Novikova N.A, Zubkova N.V., Golitsyna L.N., Kuznetsov K.V. Opredelenie markerov parvovirusa V19 v obraztsakh krovi donorov [Detection of parvovirus markers in blood samples]. Zhurnal mikrobiologii, epidemiologii i immunobiologii — Journal of Microbiology, Epidemiology and Immunobiology, 2010, no. 5, pp. 67–70.
  16. Цвиркун О.В., Москалева Т.Н., Герасимова А.Г., Тихонова Н.Т., Чава О.О., Наретя Н.Н., Архипова О.В., Фильченкова Ф.Э, Столярова Т.Л., Глухов П.С. Клинико-эпидемиологические особенности вспышки инфекционной эритемы // Эпидемиология и вакцинопрофилактика. — 2005. — № 2. — С. 21–25. Tsvirkun O.V., Moskaleva T.N., Gerasimova A.G., Tikhonova N.T., Chava O.O., Naretya N.N., Arkhipova O.V., Fil`chenkova F.E., Stolyarova T.L., Glukhov P.S. Kliniko-epidemiologicheskie osobennosti vspyshki infektsionnoy eritemy [Special clinical & epidemiology characteristics of infection erithema outbreak]. Epidemiologiya i vaktsinoprofilaktika — Epidemiology and Vaccine Protection, 2005, no. 2, pp. 21–25.
  17. Шипулин Г.А., Белковская М.Э., Мальмберг О.Л., Шипулина О.Ю., Курцер М.А., Лукаш Е.Н., Гнетецкая В.А., Пиксасова О.В., Тарасова Ю.А. Неиммунная водянка плода: диагностика и тактика // Акушерство и гинекология. — 2009. — № 2. — С. 37–40. Shipulin G.A., Belkovskaya M.E., Mal`mberg O.L., Shipulina O.Yu., Kurtser M.A., Lukash E.N., Gnetetskaya V.A., Piksasova O.V., Tarasova Yu.A. Neimmunnaya vodyanka ploda: diagnostika i taktika [Non immune dropsy of a fetus: diagnostics and tactics]. Akusherstvo i ginekologiya — Obstetrics and Gynecology, 2009, no. 2, pp. 37–40.
  18. Элижбаева М.А., Февралева И.С., Глинщикова О.А., Сильвейстрова О.Ю., Шипулина О.Ю., Домонова Э.А., Сафонова А.П., Овчинникова Е.Н., Татаева З.М., Судариков А.Б. Выявление парвовируса B19 в крови российских доноров // Гематология и трансфузиология. — 2011. — Т. 56, № 2. — С.10–13. Elizhbaeva M.A., Fevraleva I.S., Glinshchikova O.A., Sil`veystrova O.Yu., Shipulina O.Yu., Domonova E.A., Safonova A.P., Ovchinnikova E.N., Tataeva Z.M., Sudarikov A.B. Vyyavlenie parvovirusa B19 v krovi rossiyskikh donorov [Identification of parvovirus B19 in the Russian blood donors]. Gematologiya i transfuziologiya — Hematology and Transfusion, 2011, vol. 56, no. 2, pp. 10–13.
  19. Amand St., Astell J., Astell C.R. Identification and characterization of a family of 11-kDa proteins encoded by human parvovirus B19. Virology, 1993, vol. 192, рр. 121–131.
  20. Anderson L.J., Tsou C., Parker R.A., Chorba T.L., Wulff H., Tattersall P., Mortimer P.P. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J. Clin. Microbiol., 1986, vol. 24, рр. 522–526.
  21. Andersоn L.J., Gillespie S.M., Torok T.J., Hurwitz E.S., Tsou C.J., Gary G.W. Risk of infection following exposures to human parvovirus B19. Behring Inst. Mitt., 1990, vol. 85, рр. 60–63.
  22. Anderson M.J., Jones S.E., Fisher-Hoch S.P., Lewis E., Hall S.M., Bartlett C.L.R., Cohen B.J., Mortimer P.P., Pereira M.S. Human parvovirus, the cause of erithema infectiosum (fifth disease). Lancet, 1983, vol. 321, рр. 1378.
  23. Baasner A., Dettmeyer R., Graebe M., Rissland J., Madea B.PCR-based diagnosis of Enterovirus and Parvovirus B19 in paraffin-embedded heart tissue of children with suspected sudden infant death syndrome. Lab. Invest., 2003, vol. 83, рр. 1451–1455.
  24. Bailey J.M., Parvovirus B19 presenting with severe sepsis in a previously healthy 25-year-old female. J. Am. Board Fam. Med., 2006, vol. 19, no. 3, рр. 317–319.
  25. Bardeletti G., Tektoff J., Gautheron D. Rubella virus maturation and production in two host cell systems. Intervirology, 1979, vol. 11, no. 2, рр. 97–103.
  26. Baylis S.A., Shah N., Minor Ph.D. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma. J. Virol. Methods., 2004, vol. 121, no. 1, рр. 7–16.
  27. Baylis S.A. Standardization of nucleic acid amplification technique (NAT)-based assays for different genotypes of parvovirus B19: a meeting summary. Vox Sanguinis, 2008, vol. 94, рр. 74–80.
  28. Blümel J., Eis-Hübinger A.M., Stühler A., Bönsch C., Gessner M., Löwer J. Characterization of Parvovirus B19 genotype 2 in KU812Ep6 cells. J. Virol., 2005, vol. 79, no. 22, рр. 14197–14206.
  29. Botto S., Bergallo M., Sidoti F., Terlizzi M.E., Astegiano S., Ponti R., Costa C., Cavallo R. Detection of PARV4, genotypes 1 and 2, in healthy and pathological clinical specimens. New Microbiol., 2009, vol. 32, рр. 189–192.
  30. Brown K.E., Hibbs J.R., Gallinella G., Anderson S.M., Lehman E.D., McCarthy P., Young N.S. Resistance to Parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen). N. Engl. J. Med., 1994, vol. 330, no. 17, рр. 1192–1196.
  31. Brown K.E., Liu Z., Gallinella G., Wong S., Mills I.P., O’Sullivan M.G. Simian parvovirus infection: a potential zoonosis. J. Infect. Dis., 2004, vol. 190, рр. 1900–1907.
  32. Brown T., Anand A., Ritchie L.D., Clewley J.P., Reid T.M.S. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet, 1984, vol. 2, рр. 1033–1034.
  33. Centres for Disease Control. Current trends risks associated with human parvovirus B19 infection. MMWR Morb Mortal WKLY Rep., 1989, vol. 38, N 6, рр. 81–88, 93–97. — Mode of access: http://www.cdc.gov/mmwr/preview/mmwrhtml/00001348.htm.
  34. Chen Zh., Guan W., Cheng F., Chen A.Y., Qiu J.Molecular characterization of human parvovirus B19 genotypes 2 and 3. Virology, 2009, vol. 394, рр. 276–285.
  35. Chisaka H., Ito K., Niikura H., Sugawara J., Takano T., Murakami T., Ito K., Niikura H., Sugawara J., Takano T., Murakami T., Terada Y., Okamura K., Shiroishi H., Sugamura K., Yaegashi N. Clinical manifestations and outcomes of parvovirus B19 infection duting pregnancy in Tohoku. J. Exp. Med., 2006, vol. 209, рр. 277–283.
  36. Chisaka H., Morita E., Yaegashi N., Sugamura K. Parvovirus B19 and the pathogenesis of anemia. Rev. Med. Virol., 2003, vol. 13, рр. 347–359.
  37. Christensen J., Cotmore S.F., Tattersall P. A novel cellular site-specific DNA-binding protein cooperates with the viral NS1 polypeptide to initiate parvovirus DNA replication. J. Virol., 1997, vol. 71, рр. 1405–1416.
  38. Cohen B. Parvovirus B19: en expanding spectrum of disease. BMJ, 1995, vol. 311, рр. 1549–1552.
  39. Corcioli F., Zakrzewska K., Fanci R., De Giorgi V., Innocenti M., Rotellini M., Di Lollo S., Azzi A. Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V). Virol. J., 2010, vol. 7, рр. 272. — Mode of access: http://www.virologyj.com/content/7/1/272 568-1.
  40. Corcoran A., Doyle S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J. Med. Microbiol., 2004, vol. 53, рр. 459–475.
  41. Corcoran C., Hardie D., Yeats J., Smuts H. Genetic variants of Human Parvovirus B19 in South Africa: cocirculation of three genotypes and identification of a novel subtype of genotype 1. J. Clin. Microbiol., 2010, vol. 48, no. 1, рр. 137–142.
  42. Cossart Y.E., Field A.M., Cаnt B., Widdows D. Parvovius-like particles in human sera. Lancet, 1975, vol. 1, no. 7898, рр. 72–73.
  43. Cubel R.C., Garcia A.G., Pegado C.S., Ramos H.I., Foneca M.E., Clewley J.P., Cohen B.J., Nascimento J.P. Human parvovirus B19 infection and fetal hydrops fetalies in Rio de Janeiro. Brazil. Mem. Inst. Oswaldo Cruz., 1996, vol. 91, рр. 147–151.
  44. De Jong E.P., de Haan T.R., Kroes A.S., Beersma M.F., Opeces D., Walther F.J. Parvovirus B19 infection in pregnancy. J. Clin. Virol., 2006, vol. 36. рр. 1–7.
  45. De Mendonça M.C.L., de Amorim Ferreira A.M., dos Santos M.G.M., Oviedo E.C., Dal Bello M.S., Siqueira M.M., Maceira J.M.P., von Hubinger M.G., dos Santos Silva Couceiro J.N. Genotyping of human parvovirus B19 in clinical samples from Brazil and Paraguay using heteroduplex mobility assay, single-stranded conformation polymorphism and nucleotide sequencing. Mem. Inst. Oswaldo Cruz, Rio de Janeiro, 2011, vol. 106, no. 4, рр. 502–504.
  46. Doerig C., Hirt B., Antonietti J.P., Beard P. Nonstructural protein of parvoviruses B19 and minute virus of mice controls transcription. J. Virol., 1990, vol. 64, pp. 387–396.
  47. Dorsch S., Kaufmann B., Schaible U., Prohaska E., Wolf H., Modrow S. The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability. J. Gen. Virol., 2001, vol. 82, pp. 191–199.
  48. Ekman A., Hokynar K., Kakkola L., Kantola K., Hedman L., Bondén H., Gessner M., Aberham Cl., Norja P., Miettinen S., Hedman K., Söderlund-Venermo M. Biological and immunological relations among Human Parvovirus B19 genotypes 1 to 3. J. Virol., 2007, vol. 81, no. 13, рр. 6927–6935.
  49. Enders M., Weidner A., Enders G. Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany. Epidemiol. Infect., 2007, vol. 135, рр. 563–569.
  50. Enders M., Weidner A., Zoellner I., Searle K., Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat. Diagn., 2004, vol. 24, рр. 513–518.
  51. Erdman D.D., Usher M.J., Tsou C., Caul E.O., Gary G.W., Kajigaya S., Young N.S., Anderson L.J. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. J. Med. Virol., 1991, vol. 5, рр. 110–115.
  52. Ergas D., Resnitzk P., Berrebi A. Pure red blood cell aplasia associated with Parvovirus B19 infection in large granular lymphocyte. Blood, 1996, vol. 87, рр. 3523–3524.
  53. Freitas R.B., Melob F.L., Oliveira D.S., Romano C.M., Freitas M.R.C., Maĉedo O., Linhares A.C., de A. Zanotto P.M., Durigon E.L. Molecular characterization of human erythrovirus B19 strains obtained from patients with several clinical presentations in the Amazon region of Brazil. J. Clin. Virol., 2008, vol. 43, рр. 60–65.
  54. Gilbert N.L., Gyorkos T.W., Béliveau C., Rahme E., Muecke C., Soto J.C. Seroprevalence of parvovirus B19 infection in daycare educators. Epidemiol. Infect., 2005, vol. 133, рр. 299–304.
  55. Gillespie S.M., Cartter M.L., Asch S., Rokos J.B., Gary G.W., Tsou C.J., Hall D.B., Anderson L.J., Hurwitz E.S. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. J. Am. Med. Assoc., 1990, vol. 263, no. 15, рр. 2061–2065.
  56. Gratacós E., Torres P.J., Vidal J., Antolín E., Costa J., Jiménez de Anta M.T., Cararach V., Alonso P.L., Fortuny A. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J. Infect. Dis., 1995, vol. 171, рр. 1360–1363.
  57. Gray J.J., Roth C., Swygart C., Desselberger U. Human parvovirus B19 serology with recombinant VP1 and VP2 antigens: diagnosis of acute infections by detecting B19-specific IgM and IgA antibodies. Clin. Diagn. Virol., 1994, vol. 2, Iss. 6, рр. 331–341.
  58. Harger J.H., Adler S.P., Koch W.C., Harger G.F. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet. Gynecol., 1998, vol. 91, рр. 413–420.
  59. Heegaard E.D., Brown K.E. Human parvovirus B19. Clin. Microbiol. Rev., 2002, vol. 15, no. 3, рр. 485–505.
  60. Heegaard E.D., Peterson B.L., Heilmann C.L., Horsleyh A. Prevalence of parvovirus B19 and parvovirus V9 DNA and antibodies in paired bone marrow and serum samples healthy individuals. J. Clin. Microbiol., 2002, vol. 40, рр. 933–936.
  61. Hokynar K., Norja P., Hedman K., Sderlund-Venermo M. Tissue persistence and prevalence of B19 virus types 1–3. Future Virology, 2007, vol. 2, no. 4, рр. 377–388.
  62. Hübschen J.M., Mihneva Z., Mentis A.F., Schneider F., Aboudy Y., Grossman Z., Rudich H., Kasymbekova K., Sarv I., Nedeljkovic J., Tahita M.C., Tarnagda Z., Ouedraogo J.-B., Gerasimova A.G., Moskaleva T.N., Tikhonova N.T., Chitadze N., Forbi J.C., Faneye A.O., Otegbayo J.A., Charpentier E., Muller C.P. Phylogenetic analysis of human parvovirus B19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b. J. Clin. Microbiol., 2009, vol. 47, no. 11, рр. 3735–3738.
  63. Jordan J.A., DeLoia J.A. Globoside expression within the human placenta. Placenta, 1999, vol. 20, рр. 103–108.
  64. Kaikkonen L., Lankinen H., Harjunpää I., Hokynar K., Söderlund-Venermo M., Oker-Blom C., Hedman L., Hedman K. Acutephase-specific heptapeptide epitope for diagnosis of parvovirus B19 infection. J. Clin. Microbiol., 1999, vol. 37, рр. 3952–3956.
  65. Kajigaya S., Fujii H., Field A., Anderson S., Rosenfeld S., Anderson J., Shimada T., Young N.S. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc. Natl. Acad. Sci. USA., 1991, vol. 88, рр. 4646–4650.
  66. Kapoor A., Slikas E., Simmonds P., Chieochansin T., Naeem A., Shaukat S., Alam M.M., Sharif S., Angez M., Zaidi S., Delwart E. A Newly identified Bocavirus species in human stool. Brief report. JID, 2009, vol. 199, рр.196–200. — Mode of access: http://jid.oxfordjournals.org/content/199/2/196.full.pdf.
  67. Kelly H.A., Siebert D., Hammond R., Leydon J., Kiely P., Maskill W. The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol. Infect., 2000, vol. 124, рр. 449–457.
  68. Kivovich V., Gilbert L., Vuento M., Naides S.J. Parvovirus B19 genotype specific amino acid substitution in ns1 reduces the protein’s cytotoxicity in culture. Int. J. Med. Sci., 2010, vol. 7, no. 3, рр. 110–119.
  69. Koppelman M.H.G.M., Cuypers H.T.M., Emrich Th., Zaaijer H.L. Quantitative real-time detection of parvovirus B19 DNA in plasma. Transfusion, 2004, vol. 44, iss. 1, рр. 97–103.
  70. Koppelman M.H.G.M., van Swieten P., Cuijpers H.T.M. Real-time polymerase chain reaction detection of parvovirus B19 DNA in blood donations using a commercial and an in-house assay. Transfusion, 2011, vol. 51, iss. 6, pp. 1346–1354.
  71. Levy R., Weissman A., Blomberg G., Hagay Z.J. Infection by parvovirus B19 during pregnancy: a review. Obstet Gynecol Surv., 1997, vol. 52, рр. 254–259.
  72. Lou S., Xu B., Huang Q., Zhi N., Cheng F., Wong S., Brown K., Delwart E., Liu Z., Qiu J. Molecular characterization of the newly identified human parvovirus 4 in the family Parvoviridae. Virology, 2012, vol. 422, рр. 59–69.
  73. Luo W., Astell C.R. A novel protein encoded by small RNAs of parvovirus B19. Virology, 1993, vol. 195, рр. 448–455.
  74. Mani B., Gerber M., Lieby P., Boschetti N., Kempf Ch., Ros C. Molecular mechanism underlying B19 virus inactivation and comparison to other parvoviruses. Transfusion, 2007, vol. 47, рр. 1765–1774.
  75. Miller E., Fairley C.K., Cohen B.J., Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br. J. Obstet Gynaecol., 1998, vol. 105, рр. 174–178.
  76. Moffatt S., Yaegashi N., Tada K., Tanaka N., Sugamura K. Human parvovirus B19 nonstructural (NS1) protein induced apoptosis in erythroid lineage cells. J. Virol., 1998, vol. 72, рр. 3018–3028.
  77. Mori J., Field A.M., Clewley J.P., Cohen B.J. Dot blot hybridization assey of B19 virus DNA in clinical specimens. J. Clin. Microbiol., 1989, vol. 27, рр. 459–464.
  78. Mori J., Beattie P., Melton D.W., Cohen B.J., Clewley J.P. Structure and mapping of the DNA of human parvovirus B19. J. Gen. Virol., 1987, vol. 68, рр. 2797–2806.
  79. Mortimer P.P., Humphries R.K., Moore J.G., Purcel R.H., Young N.S. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature, 1983, vol. 302, рр. 426–429.
  80. Mossong J., Hens N., Friederichs V., Davidkin I., Broman M., Litwinska B., Siennicka J., Trzcinska A., Van Damme P., Beutels P., Vyse A., Shkedy Z., Aerts M., Massari M., Gabutti G. Parvovirus B19 infection in the European countries: seroepidemiology, force of infection, and maternal risk of infection. Epidemiol. Infect., 2008, vol. 136, no. 8, рр. 1059–1068.
  81. Munakata Y., Saito-Ito T., Kumura-Ishii K., Huang J., Kodera T., Ishii T., Hirabayashi Y., Koyanagi Y., Sasaki T. Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood, 2005, vol. 106, no. 10, рр. 3449–3456.
  82. Murry Ch.E., Jerome K.R., Reichenbach D.D. Fatal parvovirus myocarditis in a 5-year-old girl. Human Pathology, 2001, vol. 32, iss. 3, рр. 342–345.
  83. Musiani M., Roda A., Zerbini M., Gentilomi G., Pasini P., Gallinella G., Venturoli S. Detection of parvovirus B19 DNA in bone marrow cells by chemiluminescence in situ hybridization. J. Clin. Microbiol., 1996, vol. 34, no. 5, рр. 1313–1316.
  84. Musiani M., Pasini P., Zerbini M., Roda A., Gallinella G., Manaresi E., Venturoli S. Prenatal diagnosis of parvovirus B19-induced hydrops fetalis by chemiluminescence in situ hybridization. J. Clin. Microbiol., 1999, vol. 37, no. 7, рр. 2326–2329.
  85. Nascimento J.P., Mistchenko A., Cohen B.J. Laboratory diagnosis of acute human parvovirus B19 infection by specific IgM detection. Rev. Inst. Med. Trop. So Paulo, 1998, vol. 40, no. 4, рр. 265–266.
  86. Nyman M., Tolfvenstam T., Petersson K., Krassny C., Skjoldebrand-Sparre L., Broliden K. Detection of human parvovirus B19 infection in first-trimester fetal loss. Obstet Gynecol., 2002, vol. 99, рр. 795–798.
  87. Oliveira S.A., Camacho L.A. B., de Medeiros Pereira A.C., Faillace T.F., Setúbal S., do Nascimento J.P. Clinical and epidemiological aspects of human parvovirus B19 infection in an urban area in Brazil (Niteroi city area, State of Rio de Janeiro, Brazil). Mem. Inst. Oswaldo Cruz., 2002, vol. 97, рр. 965–970.
  88. Ozawa K., Young N. Characterization of capsid and noncapcid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J. Virol., 1987, vol. 61, рр. 2627–2630.
  89. Ozawa K., Kurtzman G., Young N.S. Replication of the B19 parvovirus in human bone marrow cell cultures. Science, 1986, vol. 233, рр. 883–886.
  90. Parsyan A., Szmaragd C., Allain J.-P., Candotti D. Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J. Gen. Virol., 2007, vol. 88, рр. 428–431.
  91. Porter H.J., Quantrill A.M., Fleming K.A. B19 parvovirus infection of myocardial cells. Lancet, 1988, vol. 1, рр. 535–536.
  92. Public Health Laboratory Service Working Party on Fifth Disease Prospective stady of human parvovirus infection in pregnancy. BMJ, 1990, vol. 300, рр. 1166–1170.
  93. Rice P.C., Cohen B.J. A school outbreak of parvovirus B19 infection investigated using salivary antibody assays. Epidemiol. Infect., 1996, vol. 116, рр. 331–338.
  94. Riipinen A., Väisänen E., Nuutila M., Sallmen M., Karikoski R., Lindbohm M.-L., Hedman K., Taskinen H., Söderlund-Venermo M. Parvovirus B19 infection in fetal deaths. CID, 2008, vol. 47, рр. 1519–1525.
  95. Rodis J.F., Quinn D.L., Gary G.W., Anderson L.J., Rosengren S., Cartter M.L., Campbell W.A., Vintzileos A.M. Management and outcomes of pregnancies complicated by human parvovirus B19 infection: a prospective study. Am. J. Obstet. Gynecol., 1990, vol. 163, рр. 1168–1171.
  96. Saikawa T., Anderson S., Momoeda M., Kajigaya S., Young N.S. Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J. Virol., 1993, vol. 67, рр. 3004–3009.
  97. Schneider B., Höne A., Tolba R.H., Fischer Y.-P., Blümel J. Eis-Hübinger A.M. Simultaneous persistence of multiple genome variants of human parvovirus B19. J. Gen. Virol., 2008, vol. 89, pp. 164–176.
  98. Schwarz T.F., Nerlich A., Hillemanns P. Detection of parvovirus B19 in fetal autopsies. Arch. Gynecol. Obstet., 1993, vol. 253, no. 4, pp. 207–213.
  99. Schwarz T.F., Roggendorf M., Hottentrger B., Deinhardt F., Enders G., Gloning K.P., Schramm T., Hansmann M. Human parvovirus B19 infection in pregnancy. Lancet ii, 1988b, pp. 566–567.
  100. Serjeant G.R., Topley J.M., Mason K., Serjeant B.E., Pattison J.R., Jones S.E., Mohamed R. Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet ii, 1981, pp. 595–597.
  101. Serke S., Schwarz T.F., Baurmann H., Kirsch A., Hottenträger B., Von Brunn A., Roggendorf M., Huhn D., Deinhardt F. Productive infection of in vitro generated haemopoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry, flow-cytometry, and DNA-hybridization. Br. J. Haematol., 1991, vol. 79, pp. 6–13.
  102. Servant A., Laperche S., Lallemand F., Marinho V., De Saint Maur G., Meritet J.F., Garbarg-Chenon A. Genetic diversity within human erythroviruses: identification of three genotypes. J. Virol., 2002, vol. 76, no. 18, pp. 9124–9134.
  103. Sevall J.S., Ritenhous J., Peter J.B. Laboratory diagnosis of parvovirus B19 infection. J. Clin. Lab. Anal., 1992, vol. 6, iss. 4, pp. 171–175.
  104. Söderlund M., Brown C.S., Cohen B.J., Hedman K. Accurate serodiagnosis of B19 parvovirus infection by measurement of IgG avidity. J. Infect. Dis., 1995, vol. 171, pp. 710–713.
  105. Söderlund M., Brown C.S., Spaan W.J., Hedman L., Hedman K. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J. Infect. Dis., 1995b, vol. 172, pp. 1431–1436.
  106. Stelma F.F., Smismans A., Goossens V.J., Bruggeman C.A., Hoebe C.J. Occupational risk of human cytomegalovirus and parvovirus B19 infection in female day care personnel in the Netherlands; a study based on seroprevalence. Eur. J. Clin. Microbiol. Infect. Dis., 2009, vol. 28, pp. 393–397.
  107. Toan N.L., Duechting A., Kremsner P.G., Song L.H., Ebinger M., Aberle S., Binh V.Q., Duy D.N., Torresi J., Kandolf R., Bock C.-Th. Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients. J. Gen. Virol., 2006, vol. 87, pp. 2941–2949.
  108. Torok T.J. Human parvovirus B19 infections in pregnancy. Pediatr Infect Dis., 1990, vol. 9, pp. 772–776.
  109. Valeur-Jensen A.K., Pedersen C.B., Westergaard T., Jensen I.P., Lebech M., Andersen P.K., Aaby P., Pedersen B.N., Melbye M. Risk factors for parvovirus B19 infection in pregnancy. JAMA, 1999, vol. 281, no. 12, pp. 1099–1105.
  110. Venturolli S., Gallinella G., Manaresi E., Gentilomi G., Musiani M., Zerbini M. IgG response to the immunoreactive region of parvovirus B19 nonstructural protein by immunoblot assay with a recombinant antigen. J. Infect. Dis., 1998, vol. 178, pp. 1826–1829.
  111. Virus Taxonomy: 2011 Release (current). — Mode of access: http://www.ictvonline.org/virusTaxonomy.asp. — Access Date: 20.01.2013.
  112. Virus Taxonomy: classification and nomenclature of viruses: Ninth Report of the International Committee on Taxonomy of Viruses. International union of microbiological societies. Ed. by A.M.Q. King [et al.]. — San Diego: Elsevier Academic Press, 2012. pp. 405–417.
  113. Weigel-Kelley K.A., Yoder M.C., Srivastava A. Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood, 2003, vol. 102, no. 12, pp. 3927–3933.
  114. Weigel-Kelley K.A., Yoder M.C., Srivastava A. Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic. J. Virol., 2001, vol. 75, no. 9, pp. 4110–4116.
  115. Wong A., Tan K.H., Tee C.S., Yeo G.S.H. Seroprevalence of Cytomegalovirus, Toxoplasma and parvovirus in pregnancy. Singapore Med J., 2000, vol. 1, no. 4, pp. 151–155.
  116. Wong S., Zhi N., Filippone C., Keyvanfar K., Kajigaya S., Brown K.E., Young N.S. Ex vivo-generated CD36+ erythroid progenitors are highly permissive to Human Parvovirus B19 replication. J. Virol., 2008, vol. 82, no. 5, pp. 2470–2476.
  117. Yaegashi N., Shiraishi H., Takeshita T., Nakamura M., Yajima A., Sugamura K. Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver. J. Virol., 1989, vol. 63, pp. 2422–2426.
  118. Yermalovich M.A., Hübschen J.M., Semeiko G.V., Samoilovich E.O., Muller C.P. Human parvovirus B19 surveillance in patients with rash and fever from Belarus. J. Med. Virol., 2012, vol. 84, no. 6, pp. 973–978.
  119. Young N.S., Brown K.E. Mechanisms of disease: Parvovirus. N. Engl. J. Med., 2004, vol. 350, no. 6, pp. 586–597.
  120. Zakrzewska K., Cortivo R., Tonello C., Panfilo S., Abatangelo G., Giuggioli D., Ferri C., Corcioli F., Azzi A. Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures. Virus Res., 2005, vol. 114, pp. 1–5.
  121. Zuffi E., Manaresi E., Gallinella G., Gentilomi G.A., Venturoli S., Zerbini M., Musiani M.Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans. Viral Immunol., 2001, vol. 14, no. 2, pp. 151–158.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Lavrentyeva I.N., Antipova A.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 64788 от 02.02.2016.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies